# OneBlood, Inc. – FDA Inspection, Mar 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/5a8084e9-9266-4959-a96d-357e42fcf701
Source feed: FDA_Inspections

> FDA inspection 1309376 of OneBlood, Inc., March 26, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309376
- Company Name: OneBlood, Inc.
- Inspection Date: 2026-03-26
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Florida District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1121342 - 2020-02-06
- FDA Inspection 1035764 - 2017-11-14
- FDA Inspection 987798 - 2016-08-02
- FDA Inspection 893894 - 2014-08-26
- FDA Inspection 807212 - 2012-11-16

## Related Officers

- [Company Rep](https://www.keypedia.com/people/mizanne-e-lewis/c79964ac-5163-44a2-89e9-8cc8775de9b4)

Company: https://www.keypedia.com/companies/oneblood-inc/f0744635-fe27-4f79-b568-ebe3368db885

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9
